do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline Can patients take and together? Clinical Use of DPP-4 Inhibitors
Description
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

Study population The study population included subjects residing in Denmark
Maintenance dosing Not all of these experimental drugs will necessarily make it to market, but one of the primary roles they may play if they do is as long-term maintenance dosing for people whove lost a sufficient amount of weight on injectable medications, Dushay said

How Much Sodium Should I Eat Per Day

First, the BBB might limit access to brain areas where GLP-1R could potentially mediate effects on energy expenditure
